NLRP3 and major depressive disorder: After fluoxetine treatment, the serum levels of RvD1, NLRP3, and IL-1β in adolescent patients with MDD were significantly decreased (P < 0.01), whereas IL-4 was significantly increased (P < 0.001) compared with that before treatment (P < 0.001).